Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02145910
Title Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Thomas Jefferson University
Indications

melanoma

Therapies

Vemurafenib

Age Groups: adult
Covered Countries

Additional content available in CKB BOOST